Reply to M. Sorigue et al

Affiliations

¹ Michael MacManus, MD, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Richard Fisher, MD, PhD, and Bev McClure, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and John F. Seymour, PhD, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, and Royal Melbourne Hospital, Parkville, Victoria, Australia.

Comment

Michael MacManus et al. J Clin Oncol. 2019.

. 2019 Jan 20;37(3):257-258.

doi: 10.1200/JCO.2018.18.01309. Epub 2018 Nov 26.

¹ Michael MacManus, MD, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Richard Fisher, MD, PhD, and Bev McClure, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and John F. Seymour, PhD, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, and Royal Melbourne Hospital, Parkville, Victoria, Australia.

No abstract available

Comment on

Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.
MacManus M, Fisher R, Roos D, O'Brien P, Macann A, Davis S, Tsang R, Christie D, McClure B, Joseph D, Jayamohan J, Seymour JF. MacManus M, et al. J Clin Oncol. 2018 Oct 10;36(29):2918-2925. doi: 10.1200/JCO.2018.77.9892. Epub 2018 Jul 5. J Clin Oncol. 2018. PMID: 29975623 Clinical Trial.
Further Examining the TROG 99.03 Trial in Early-Stage Follicular Lymphoma: Cure Rate and the Role of Positron Emission Tomography.
Sorigue M, Sancho JM. Sorigue M, et al. J Clin Oncol. 2019 Jan 20;37(3):256-257. doi: 10.1200/JCO.18.00854. Epub 2018 Nov 26. J Clin Oncol. 2019. PMID: 30475666 No abstract available.